The development of contraceptive vaccines

Expert Opinion on Investigational Drugs

Volumn 11, Issue 9, 2002, Pages 1225-1237

  Delves, Peter J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antifertility; Contraception; Glycoprotein hormones; Oocytes; Spermatozoa; Vaccine

Indexed keywords

ADJUVANT; ALUMINUM POTASSIUM SULFATE; B LYMPHOCYTE ANTIBODY; CHITOSAN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN ANTIBODY; CONTRACEPTIVE VACCINE; DIPHTHERIA TOXOID; DRUG CARRIER; EPITOPE; ESTROGEN; FOLLITROPIN; GESTAGEN; GONADORELIN; HYALURONIDASE; IMMUNOGLOBULIN G; INHIBIN; LACTATE DEHYDROGENASE ISOENZYME; LUTEINIZING HORMONE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MURAMYL DIPEPTIDE; NEUTRALIZING ANTIBODY; ORAL CONTRACEPTIVE AGENT; PROTEIN A; RECOMBINANT CHORIONIC GONADOTROPIN; RIBOFLAVIN BINDING PROTEIN; SEX HORMONE; TETANUS TOXOID; THYROTROPIN; UNINDEXED DRUG;

ACTIVE IMMUNIZATION; ADULT; BIRTH CONTROL; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFICACY; DRUG FORMULATION; FAMILY PLANNING; FEMALE; GAMETE; HUMAN; IMMUNOCONTRACEPTION; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; RAT; REVIEW; SIDE EFFECT;

ANIMALS; CLINICAL TRIALS, PHASE II; FEMALE; HUMANS; MALE; TECHNOLOGY, PHARMACEUTICAL; VACCINES, CONTRACEPTIVE;

EID: 0036739774     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.11.9.1225     Document Type: Review

References (95)

1. Current reversible contraceptive methods: A global perspective
2. Evidence for a unique N-linked glycan associated with human infertility on sperm CD52: A candidate contraceptive vaccinogen
3. Time to pardon the IUD?
4. Ischaemic stroke and combined oral contraceptives: Results of an international, multicentre, case-control study
5. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: Results of an international, multicentre, case-control study
6. Oral contraceptives and the risk of breast cancer
7. Oral contraceptives and neoplasia
8. Antifertility vaccines
9. Immunological reactions and infertility
10. Infertility, immunological causes of
11. Human sperm proteome: Immunodominant sperm surface antigens identified with sera from infertile men and women
12. Vaccines for fertility regulation of wild and domestic species
13. Development of an antifertility vaccine for pets based on active immunization against luteinizing hormone-releasing hormone
14. Case studies in wildlife immunocontraception: Wild and feral equids and white-tailed deer
15. Possible mechanisms of mammalian immunocontraception
16. A vaccine that prevents pregnancy in women
17. A study of the secretory immune system of the female genital tract
18. Induction of mucosal immune responses in the human genital tract
19. Human chorionic gonadotropin-beta Subunit gene expression in cultured human fetal and cancer cells of different types and origins
20. Embryonic signals during the periimplantation period in primates
21. Implantation and the survival of early pregnancy
22. Crystal structure of chorionic gonadotropin
23. Vaccines and passive immunological approaches for the control of fertility and hormone-dependent cancers
24. Absence of corpus luteum rescue by chorionic gonadotropin in women immunized with a contraceptive vaccine
25. Progress in the development of human chorionic gonadotropin antifertility vaccines
26. Phase I clinical trial of a World Health Organisation birth control vaccine
27. Antifertility vaccines
28. Assays of antibodies to a C-terminal peptide or the entire β-subunit of human chorionic gonadotropin
29. Development of male contraceptive vaccine-a perspective
30. Is FSH based contraceptive vaccine a feasible proposition for the human male?
31. Prospects of riboflavin carrier protein (RCP) as an antifertility vaccine in male and female mammals
32. Immunocontraceptive potential of major antigenic determinants of chicken riboflavin carrier protein in the female rat
33. Active immunization against gonadotropin-releasing hormone combined with androgen supplementation is a promising antifertility vaccine for males
34. Comparative efficacy of two immunocontraceptive vaccines
35. Immunoneutralisation of gonadotrophin releasing hormone: A potential treatment for oestrogen-dependent breast cancer
36. A novel mammalian receptor for the evolutionarily conserved Type II GnRH
37. A gonadotropin-releasing hormone (GnRH) receptor specific for GnRH II in primates
38. Immunoneutralisation of GnRH-I, without cross-reactivity to GnRH-II, in the development of a highly specific anti-fertility vaccine for clinical and veterinary use
39. Enhanced immunogenicity of a contraceptive vaccine using diverse synthetic carriers with permissible adjuvant
40. Immune stimulating activity of two new chitosan-containing adjuvant formulations
41. Biodegradable delivery system for a birth control vaccine: Immunogenicity studies in rats and monkeys
42. Reversible protection of disulfide bonds followed by oxidative folding render recombinant hCGβ highly immunogenic
43. High expression of human chorionic gonadotrophin β-subunit using a synthetic vaccinia virus promoter
44. Immunogenicity of a fusion protein linking the β subunit carboxyl terminal peptide (CTP) of human chorionic gonadotropin to the B subunit of Escherichia coli heat-labile enterotoxin (LTB)
45. Identification and selective destruction of shared epitopes in human chorionic gonadotropin beta subunit
46. Elimination of luteinizing hormone cross-reactive epitopes from human chorionic gonadotropin
47. Refocusing of B-cell responses following a single amino acid substitution in an antigen
48. Contraceptive vaccine strategies that target the zona pellucida
49. Molecular characterization of non-human primate zona pellucida glycoproteins
50. Analysis of recombinant mouse zona pellucida protein 2 (ZP2) constructs for immunocontraception
51. Immunization of monkeys with recombinant complimentary deoxyribonucleic acid expressed zona pellucida proteins
52. Zona pellucida antigens: Targets for contraceptive vaccines
53. Primate response to immunization with a homologous zona pellucida peptide
54. Failure of female baboons (Papio anubis) to conceive following immunization with recombinant non-human primate zona pellucida glycoprotein-B expressed in Escherichia coli
55. The contraceptive potential of ZP3 and ZP3 peptides in a primate model
56. Effectiveness of zona pellucida protein ZPB as an immunocontraceptive antigen
57. Mapping of dominant B-cell epitopes of a human zona pellucida protein (ZPI)
58. Vaccination with a synthetic zona pellucida peptide produces long-term contraception in female mice
59. The potential of the zona pellucida as a target for immunocontraception
60. A zona pellucida peptide vaccine induces antibodies and reversible infertility without ovarian pathology
61. Immunoreactivity and in-vitro effect on human sperm-egg binding of antibodies against peptides corresponding to bonnet monkey zona pellucida-3 glycoprotein
62. A contraceptive peptide vaccine targeting sulfated glycoprotein ZP2 of the mouse zona pellucida
63. Species specificity of human and murine anti-ZP3 synthetic peptide antisera and use of the antibodies for localization and identification of ZP3 or ZPC domains of functional significance
64. Analysis of B cell epitopes of a glycoprotein porcine zona pellucida (pZP1)
65. Delineation of a conserved B cell epitope on Bonnet monkey (Macaca radiata) and human zona pelludda glycoprotein-B by monoclonal antibodies demonstrating inhibition of sperm-egg binding
66. Immunocontraception with zona pellucida proteins
67. Contraceptive potential of synthetic peptides of zona pellucida protein (ZPA)
68. Sperm antigens and their use in the development of an immunocontraceptive
69. Infertility in female rabbits immunized with lactate dehydrogenase X
70. Reversible contraception in female baboons immunized with a synthetic epitope of sperm-specific lactate dehydrogenase
71. Colinear synthesis of an antigen-specific B-cell epitope with a 'promiscuous' tetanus toxin T-cell epitope: A synthetic peptide immunocontraceptive
72. 4 as a contraceptive vaccine
73. Identification of sperm antigen targets for immunocontraception: B-cell epitope analysis of Sp17
74. A chimeric sperm peptide induces antibodies and strain-specific reversible infertility in mice
75. Fully effective contraception in male and females guinea pigs immunized with the sperm protein PH-20
76. Reversible contraceptive effect of PH-20 immunization in male guinea pigs
77. Molecular cloning of the human and monkey sperm surface protein PH-20
78. Mechanism of infertility in male guinea pigs immunized with sperm PH-20
79. Characterization of the fertilization antigen 1 for the development of a contraceptive vaccine
80. Recombinant fertilization antigen-1 causes a contraceptive effect in actively immunized mice
81. Vaccine for contraceptive targeting sperm
82. Effect of immunization with synthetic peptide corresponding to region 1-17 of human seminal plasma inhibin on fertility of male rats
83. Biochemical and morphological characterization of intraacrosomal antigen SP-10 from human sperm
84. Immunological response in the primate oviduct to a defined recombinant sperm immunogen
85. Sequence homology among sperm antigens involved in mammalian fertilization: Search for a common epitope for immunocontraception
86. Fertilization-related sperm antigens and their immunocontraceptive potentials
87. RASA, a recombinant single-chain variable fragment (scFv) antibody directed against the human sperm surface: Implications for novel contraceptives
88. Testis-specific antigen (TSA-1) is expressed in murine sperm and its antibodies inhibit fertilization
89. Immune responses in the epididymus: Implications for immunocontraception
90. Immune response of male baboons to testis-specific LDH-C(4)
91. Immunization of female cynomolgus macaques with a synthetic epitope of sperm-specific lactate dehydrogenase results in high antibody titers but does not reduce fertility
92. Effect of immunization of hamsters against recombinant P26h on fertility rates
93. A combinatorial phage display library for the generation of specific Fab fragments recognizing human spermatozoa and inhibiting fertilizing capacity in vitro
94. Regain of fertility and normality of progeny born during below protective threshold antibody titers in women immunized with the HSD-hCG vaccine
95. Immunological hazards associated with vaccination of humans